Derynck Mika K
SEC CIK 1865125 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ELVN | Enliven Therapeutics, Inc. | Dir | 158.8K | — | $9.56M | 2 | 2026-08-04 | 2026-08-04 |
Most active insiders at ELVN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ORBIMED ADVISORS LLC | 10% | — | $51.68M |
| 2 | Derynck Mika K | Dir | — | $9.56M |
| 3 | Collins Helen Louise | Chief MEDICAL Off | — | $5.39M |
| 4 | Lyssikatos Joseph P | CSO | — | $4.88M |
| 5 | Patel Anish | COO | — | $1.74M |
| 6 | Hohl Benjamin | CFO | — | $1.60M |
| 7 | Kunkel Lori Anne | Dir | — | $850.3K |
| 8 | Kintz Samuel | Pres AND CEO, Dir | — | $613.6K |
| 9 | Heyman Richard A. | Dir | — | $413.4K |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-08-06 20:18 | 2026-08-04 | ELVN | Enliven Therapeutics, Inc. | Derynck Mika K | Dir | M - OptEx | $10.84 | +158.8K | 158.8K | New | +$1.72M |
| DT | 2026-08-06 20:18 | 2026-08-04 | ELVN | Enliven Therapeutics, Inc. | Derynck Mika K | Dir | S - Sale+OE | $60.21 | -158.8K | 0 | -100% | -$9.56M |
Purchase Sale Sale after option exercise All abbreviations